Trinity Biotech Plc (TRIB)
5.69
-0.63
(-9.97%)
USD |
NASDAQ |
Oct 02, 16:00
5.46
-0.23
(-4.04%)
After-Hours: 20:00
Trinity Biotech EPS Diluted (Quarterly) : -6.853 for March 31, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | -6.853 |
| December 31, 2025 | -28.13 |
| September 30, 2025 | -8.219 |
| June 30, 2025 | -9.734 |
| March 31, 2025 | -14.43 |
| December 31, 2024 | -38.09 |
| September 30, 2024 | -0.4582 |
| June 30, 2024 | -0.7138 |
| March 31, 2024 | -0.3738 |
| December 31, 2023 | -0.7178 |
| September 30, 2023 | -0.8768 |
| June 30, 2023 | -0.782 |
| March 31, 2023 | -0.7612 |
| December 31, 2022 | -40.02 |
| September 30, 2022 | -35.01 |
| June 30, 2022 | -42.54 |
| March 31, 2022 | -2.498 |
| December 31, 2021 | 0.3636 |
| September 30, 2021 | 9.05 |
| June 30, 2021 | 0.9886 |
| March 31, 2021 | 0.2942 |
| December 31, 2020 | 1.854 |
| September 30, 2020 | 1.391 |
| June 30, 2020 | -0.351 |
| March 31, 2020 | 0.0486 |
| Date | Value |
|---|---|
| December 31, 2019 | 0.2682 |
| September 30, 2019 | 0.006 |
| June 30, 2019 | -1.293 |
| March 31, 2019 | -0.0504 |
| December 31, 2018 | 0.2926 |
| September 30, 2018 | 0.2144 |
| June 30, 2018 | 0.14 |
| March 31, 2018 | 0.09 |
| December 31, 2017 | 0.3254 |
| September 30, 2017 | 0.104 |
| June 30, 2017 | 0.2064 |
| March 31, 2017 | 0.25 |
| December 31, 2016 | 0.8567 |
| September 30, 2016 | -0.1134 |
| June 30, 2016 | 0.38 |
| March 31, 2016 | -0.28 |
| December 31, 2015 | 0.4932 |
| September 30, 2015 | 2.070 |
| June 30, 2015 | 0.4594 |
| March 31, 2015 | 0.744 |
| December 31, 2014 | 0.8193 |
| September 30, 2014 | 0.8962 |
| June 30, 2014 | 0.9313 |
| March 31, 2014 | 0.9415 |
| December 31, 2013 | 1.079 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| DBV Technologies SA | -0.5804 |
| Cellectis SA | -0.2165 |
| Akari Therapeutics Plc | -2.404 |
| Autolus Therapeutics Plc | -0.1472 |
| Evaxion AS | -0.4464 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -4.416M |
| Revenue (Quarterly) | 10.84M |
| Total Expenses (Quarterly) | 15.26M |
| Enterprise Value | 136.51M |
| Profit Margin (Quarterly) | -40.74% |
| Earnings Yield | -930.2% |